FDA grants priority review to Insmed's Arikayce for MAC lung disease
The U.S. Food and Drug Administration has accepted and granted Priority Review to a Supplemental New Drug Application (sNDA) filed ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

